Overview
Kitako Tabata practices practicing medicine in Morioka, Japan.
Their clinical expertise encompasses Late-Onset Retinal Degeneration and Ganglion Cyst.
They are actively involved in clinical research, co-authoring 20 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kitako Tabata
Is Kitako Tabata a top-rated expert for Late-Onset Retinal Degeneration?
MediFind is an objective health platform that identifies experts based on real-world data. Kitako Tabata is classified as an Experienced expert for Late-Onset Retinal Degeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kitako Tabata participate in research or clinical trials?
Yes. Kitako Tabata has published 20 articles and abstracts on conditions like Late-Onset Retinal Degeneration. You can view a list of Kitako Tabata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Ganglion CystTabata isExperienced. Learn about Ganglion Cyst.
- Late-Onset Retinal DegenerationTabata isExperienced. Learn about Late-Onset Retinal Degeneration.